Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Supriya Lifescience
Join Channel
Consolidated Standalone

Supriya Lifescience

₹378 9.8 | 2.7%

Market Cap ₹3042 Cr.

Stock P/E 25.3

P/B 3.9

Current Price ₹378

Book Value ₹ 97.3

Face Value 2

52W High ₹423.5

Dividend Yield 0.16%

52W Low ₹ 219.1

Edit Ratio

Supriya Lifescience Research see more...

Stocx User

Equity Research: Supriya Lifescience Ltd.

Overview Inc. Year: 2008Industry: Pharmaceuticals & Drugs

Supriya Lifescience Ltd., a bulk drugs organisation, engages within the research and development, manufacture, and sale of active pharmaceutical elements worldwide. It gives energetic pharmaceutical substances, which includes anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, anti-hypertensive, anti-malarial products, as well as nutrients, feed components, xanthine derivatives and drinks, and phytochemicals, in addition to gives intermediates. The organization was established in 1987 and is based in Mumbai, India.

Read More..

Supriya Lifescience Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Supriya Lifescience Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 148 117 181 101 112 105 142 132 140 140
Other Income 3 5 4 2 3 3 2 3 2 3
Total Income 151 122 185 104 115 108 144 135 143 143
Total Expenditure 54 79 106 70 84 91 87 88 108 99
Operating Profit 97 44 79 34 31 17 57 47 34 45
Interest 17 1 1 1 1 1 1 1 0 0
Depreciation 2 3 3 3 3 3 3 4 4 4
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 78 40 75 30 27 13 53 43 30 40
Provision for Tax 20 0 29 5 11 3 15 14 6 10
Profit After Tax 58 40 46 25 17 10 38 29 24 30
Adjustments -0 0 -0 -0 0 0 0 -0 0 -0
Profit After Adjustments 58 40 46 25 17 10 38 29 24 30
Adjusted Earnings Per Share 8 4.9 5.7 3.1 2.1 1.2 4.7 3.5 3 3.7

Supriya Lifescience Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 92 113 138 171 184 213 278 312 391 530 461 554
Other Income 3 2 2 2 7 9 8 11 5 8 10 10
Total Income 95 115 140 173 191 222 286 323 396 538 471 565
Total Expenditure 81 98 121 151 166 191 213 213 218 316 332 382
Operating Profit 14 16 20 22 25 31 73 109 178 222 138 183
Interest 5 6 7 10 12 11 10 7 4 4 3 2
Depreciation 2 2 2 4 5 5 5 6 7 10 12 15
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 7 9 10 8 8 14 57 96 167 207 123 166
Provision for Tax 3 2 2 2 2 6 18 23 44 55 34 45
Profit After Tax 5 6 8 6 6 9 39 73 124 152 90 121
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 6 8 6 6 9 39 73 124 152 90 121
Adjusted Earnings Per Share 0.4 0.9 1.1 0.8 0.8 1.2 5.4 10 16.9 18.9 11.2 14.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -13% 14% 17% 17%
Operating Profit CAGR -38% 8% 35% 26%
PAT CAGR -41% 7% 58% 34%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 72% NA% NA% NA%
ROE Average 14% 36% 44% 33%
ROCE Average 19% 41% 42% 28%

Supriya Lifescience Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 26 30 37 42 46 55 94 149 269 616 699
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 8 14 20 34 45 35 8 2 0 0 0
Other Non-Current Liabilities 2 3 4 5 6 10 16 29 31 19 25
Total Current Liabilities 65 83 115 150 144 146 135 155 146 100 96
Total Liabilities 101 130 176 231 241 245 253 336 445 735 820
Fixed Assets 39 45 61 75 89 91 85 98 100 190 262
Other Non-Current Assets 1 7 11 27 38 35 36 40 80 47 94
Total Current Assets 62 78 103 129 115 120 133 198 265 498 465
Total Assets 101 130 176 231 241 245 253 336 445 735 820

Supriya Lifescience Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 3 4 5 7 6 9 12 75 89 228
Cash Flow from Operating Activities 0 5 -6 14 27 28 49 116 76 49 66
Cash Flow from Investing Activities 0 -14 -23 -33 -27 -5 5 -25 -47 -60 -133
Cash Flow from Financing Activities 0 10 30 21 -2 -20 -50 -29 -15 150 -3
Net Cash Inflow / Outflow 0 1 1 2 -2 3 4 62 15 139 -70
Closing Cash & Cash Equivalent 0 4 5 7 6 9 12 75 89 228 158

Supriya Lifescience Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.44 0.86 1.12 0.78 0.77 1.19 5.39 10.03 16.89 18.86 11.16
CEPS(Rs) 0.58 1.12 1.46 1.32 1.42 1.92 6.13 10.9 17.81 20.12 12.63
DPS(Rs) 0.04 0.07 0.08 0.2 0 0 0 2 0.54 0.6 0.6
Book NAV/Share(Rs) 1.67 3.29 4.28 4.76 5.51 7.47 12.82 20.39 36.7 76.5 86.91
Core EBITDA Margin(%) 11.29 12.22 11.43 10.55 8.78 9.17 20.05 27.36 40.18 36.36 24.87
EBIT Margin(%) 12.56 12.15 11.38 9.72 10.16 10.53 20.96 28.67 39.77 35.93 24.52
Pre Tax Margin(%) 7.68 7.1 6.77 4.33 4.13 6.04 17.77 26.76 38.82 35.21 23.91
PAT Margin (%) 4.97 5.23 5.47 3.06 2.9 3.64 12.27 20.41 28.68 25.8 17.4
Cash Profit Margin (%) 6.51 6.85 7.13 5.18 5.34 5.87 13.96 22.19 30.25 27.51 19.69
ROA(%) 5.3 5.42 5.37 2.8 2.4 3.59 15.82 24.9 31.61 25.73 11.56
ROE(%) 29.89 29.57 29.61 17.2 15.05 18.38 53.11 60.42 59.17 34.34 13.66
ROCE(%) 21.78 19.43 15.83 12.27 11.48 13.8 36.52 49.67 60.12 43.34 18.72
Receivable days 62.6 69.36 76.86 76.12 86.01 78.48 64.39 57.07 53.35 58.51 70.62
Inventory Days 102.45 92 84.22 90.25 85.36 53.26 35.46 40.7 51.64 51.1 73.53
Payable days 141.64 138.85 125.55 135.29 134.28 111.04 106.71 123.24 143.03 93.2 114.26
PER(x) 0 0 0 0 0 0 0 0 0 26.13 17.08
Price/Book(x) 0 0 0 0 0 0 0 0 0 6.44 2.19
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0.12 0.31
EV/Net Sales(x) 0.51 0.55 0.71 0.8 0.81 0.67 0.37 0.31 -0.01 7.09 3.02
EV/Core EBITDA(x) 3.4 3.77 5.04 6.2 6.07 4.66 1.41 0.87 -0.03 16.97 10.07
Net Sales Growth(%) 17.69 22.75 21.95 23.79 7.53 16.03 30.49 12.17 25.53 35.49 -13.04
EBIT Growth(%) 13.09 18.88 17.38 5.98 9.51 27.22 166.98 53.1 66.27 23.37 -40.12
PAT Growth(%) 3.76 29.41 30.9 -30.62 -0.56 54.18 351.7 86.19 68.38 22.83 -40.81
EPS Growth(%) 798.78 94.11 30.89 -30.62 -0.57 54.18 351.69 86.19 68.38 11.69 -40.81
Debt/Equity(x) 2.46 2.56 3.15 3.7 3.47 2.39 0.96 0.55 0.26 0.03 0.02
Current Ratio(x) 0.95 0.95 0.9 0.86 0.8 0.82 0.98 1.27 1.82 4.99 4.85
Quick Ratio(x) 0.49 0.58 0.56 0.5 0.53 0.6 0.76 0.96 1.32 4.06 3.64
Interest Cover(x) 2.57 2.41 2.47 1.8 1.69 2.34 6.59 15.05 42.01 50.37 40.43
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0.01 0.01

Supriya Lifescience Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 68.24 68.24 68.24 68.24 68.24 68.28 68.3 68.3 68.3 68.3
FII 10.3 7.13 5.99 6.79 6.24 5.65 5.73 5.34 4.56 5.36
DII 7.9 7.73 10.33 8.88 7.89 7.65 7.55 7.17 5.39 5.3
Public 13.56 16.9 15.44 16.09 17.63 18.42 18.43 19.19 21.76 21.04
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 58% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 36%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 93.2 to 114.26days.
  • Stock is trading at 3.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Supriya Lifescience News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!